Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New ACAT inhibitors synthesized at Sumitomo

Aug. 31, 1998

Columbia Laboratories develops hormone replacement tablet for men

Aug. 31, 1998

Unimed's Androgel shows promising phase II results

Aug. 31, 1998

Another beta3-adrenergic agent added to the BMS pipeline

Aug. 28, 1998

Ergo Science submits amendment to Ergoset NDA

Aug. 28, 1998

Bristol-Myers Squibb program on beta3-adrenoceptor agonists outlined at ACS

Aug. 27, 1998

Fuji Chemical patents new treatment for kidney disease in diabetic patients

Aug. 27, 1998

Selective alphav/beta3 integrin receptor antagonists from DuPont Pharmaceuticals

Aug. 27, 1998

Further international approvals, product launches announced for Muse

Aug. 27, 1998

Advisory committee recommends European approval for Viagra

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...